Investing.com - Financial Markets Worldwide

Perrigo sells Dermacosmetics business to KKR-backed firm for up to €327 million

Published 14/07/2025, 13:56
© Reuters.
PRGO
1.13%

Investing.com -- Perrigo said on Monday it has agreed to sell its Dermacosmetics business to Kairos Bidco, an investment vehicle backed by KKR, for up to €327 million as part of its strategy to streamline its portfolio.

The deal includes €300 million in upfront cash payment and up to €27 million in milestone payments over a three-year period, according to the terms of the agreement.

The Dermacosmetics unit includes several brands such as ACO, Biodermal, Emolium and Iwostin.

The business generated net sales of approximately €125 million in 2024.

Perrigo plans to use the proceeds from the transaction for capital allocation priorities, including strengthening its balance sheet.

The transaction is expected to close in the first quarter of 2026.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.